Compounds > technetium tc 99m sestamibi
Page last updated: 2024-08-16

technetium tc 99m sestamibi and Spinal Neoplasms

technetium tc 99m sestamibi has been researched along with Spinal Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kirton, A; Kloiber, R; Rigel, J; Wolff, J1
Alakavuklar, M; Berk, H; Capa, G; Değirmenci, B; Derebek, E; Durak, H; Havitçioğlu, H; Sekeroğlu, B1

Other Studies

2 other study(ies) available for technetium tc 99m sestamibi and Spinal Neoplasms

ArticleYear
Evaluation of pediatric CNS malignancies with (99m)Tc-methoxyisobutylisonitrile SPECT.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2002, Volume: 43, Issue:11

    Topics: Adolescent; Brain Neoplasms; Brain Stem Neoplasms; Central Nervous System Neoplasms; Child; Child, Preschool; Female; Glioma; Humans; Magnetic Resonance Imaging; Male; Pilot Projects; Radiopharmaceuticals; Spinal Neoplasms; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon

2002
Tc-99m sestamibi imaging as an indicator of P-glycoprotein expression in metastatic pheochromocytoma.
    Clinical nuclear medicine, 1998, Volume: 23, Issue:9

    Topics: Adrenal Gland Neoplasms; Aged; ATP Binding Cassette Transporter, Subfamily B, Member 1; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Liver Neoplasms; Male; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals; Spinal Neoplasms; Technetium Tc 99m Sestamibi

1998